482 related articles for article (PubMed ID: 7923545)
1. Cost-effectiveness analysis and policy choices: investing in health systems.
Murray CJ; Kreuser J; Whang W
Bull World Health Organ; 1994; 72(4):663-74. PubMed ID: 7923545
[TBL] [Abstract][Full Text] [Related]
2. A reassessment of the cost-effectiveness of water and sanitation interventions in programmes for controlling childhood diarrhoea.
Varley RC; Tarvid J; Chao DN
Bull World Health Organ; 1998; 76(6):617-31. PubMed ID: 10191558
[TBL] [Abstract][Full Text] [Related]
3. Costs of nine common mental disorders: implications for curative and preventive psychiatry.
Smit F; Cuijpers P; Oostenbrink J; Batelaan N; de Graaf R; Beekman A
J Ment Health Policy Econ; 2006 Dec; 9(4):193-200. PubMed ID: 17200596
[TBL] [Abstract][Full Text] [Related]
4. Ramsey waits: allocating public health service resources when there is rationing by waiting.
Gravelle H; Siciliani L
J Health Econ; 2008 Sep; 27(5):1143-54. PubMed ID: 18468707
[TBL] [Abstract][Full Text] [Related]
5. The role of resource allocation models in selecting clinical preventive services.
Wang LY; Haddix AC; Teutsch SM; Caldwell B
Am J Manag Care; 1999 Apr; 5(4):445-54. PubMed ID: 10387384
[TBL] [Abstract][Full Text] [Related]
6. Cost of depression in Europe.
Sobocki P; Jönsson B; Angst J; Rehnberg C
J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
[TBL] [Abstract][Full Text] [Related]
7. Accounting for the cost of scaling-up health interventions.
Johns B; Baltussen R
Health Econ; 2004 Nov; 13(11):1117-24. PubMed ID: 15386683
[TBL] [Abstract][Full Text] [Related]
8. The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade).
Kobelt G; Andlin-Sobocki P; Brophy S; Jönsson L; Calin A; Braun J
Rheumatology (Oxford); 2004 Sep; 43(9):1158-66. PubMed ID: 15226514
[TBL] [Abstract][Full Text] [Related]
9. The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making.
Palmer AJ; Roze S; Valentine WJ; Minshall ME; Foos V; Lurati FM; Lammert M; Spinas GA
Curr Med Res Opin; 2004 Aug; 20 Suppl 1():S5-26. PubMed ID: 15324513
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of group psychotherapy for depression in Uganda.
Siskind D; Baingana F; Kim J
J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
[TBL] [Abstract][Full Text] [Related]
11. Generalised cost-effectiveness analysis: an aid to decision making in health.
Hutubessy RC; Baltussen RM; Torres-Edejer TT; Evans DB
Appl Health Econ Health Policy; 2002; 1(2):89-95. PubMed ID: 14619255
[TBL] [Abstract][Full Text] [Related]
12. Organizational and client determinants of cost in outpatient substance abuse treatment.
Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of tacrolimus ointment vs. standard treatment in patients with moderate and severe atopic dermatitis: a health-economic model simulation based on a patient survey and clinical trial data.
Hjelmgren J; Svensson A; Jörgensen ET; Lindemalm-Lundstam B; Ragnarson Tennvall G
Br J Dermatol; 2007 May; 156(5):913-21. PubMed ID: 17263826
[TBL] [Abstract][Full Text] [Related]
14. Conquering the intolerable burden of malaria: what's new, what's needed: a summary.
Breman JG; Alilio MS; Mills A
Am J Trop Med Hyg; 2004 Aug; 71(2 Suppl):1-15. PubMed ID: 15331814
[TBL] [Abstract][Full Text] [Related]
15. The economics of effective AIDS treatment in Thailand.
Over M; Revenga A; Masaki E; Peerapatanapokin W; Gold J; Tangcharoensathien V; Thanprasertsuk S
AIDS; 2007 Jul; 21 Suppl 4():S105-16. PubMed ID: 17620745
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States.
Shepard CW; Ortega-Sanchez IR; Scott RD; Rosenstein NE;
Pediatrics; 2005 May; 115(5):1220-32. PubMed ID: 15867028
[TBL] [Abstract][Full Text] [Related]
17. An economic approach to health care.
Homik JE; Suarez-Almazor M
Best Pract Res Clin Rheumatol; 2004 Apr; 18(2):203-18. PubMed ID: 15121040
[TBL] [Abstract][Full Text] [Related]
18. Using costs in cost-effectiveness models for chronic diseases: lessons from diabetes.
Hoerger TJ
Med Care; 2009 Jul; 47(7 Suppl 1):S21-7. PubMed ID: 19536014
[TBL] [Abstract][Full Text] [Related]
19. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
Griebsch I; Coast J; Brown J
Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis in a setting of budget constraints--is it equitable?
Ubel PA; DeKay ML; Baron J; Asch DA
N Engl J Med; 1996 May; 334(18):1174-7. PubMed ID: 8602185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]